Search Results 501-510 of 17120 for pharmacogenetics

1. Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

   Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...

2. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

   The purpose of this study is to see how well lorvotuzumab mertansine works in treating younger patients with Wilms tumor, rhabdomyosarcoma, neuroblastoma, ...

3. Mayo Clinic Family Medicine Resident Wellness Study

   About this study. The objectives of this study are to better understand the association between sleep characteristics (sleep disruptions and deprivations) ...

4. Inflammatory Bowel Disease Treatment And Response To Therapy - Mayo Clinic

   The purpose of this study is to Identify baseline and early treatment genetic, molecular, and cellular drivers of 4-month endoscopic response to anti-IL-23, ...

5. Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

6. Patient Centered Approaches to Gene Editing Research Study - Mayo Clinic

   The purpose of this study is to elicit clinicians' and scientists' views, ethical concerns, clinical aspirations and governance needs regarding prenatal gene ...

7. Filgotinib In The Induction And Maintenance Of Remission In Adults With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

8. Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as cisplatin ...

9. A Study to Establish a Product Surveillance Registry (DTPAS) Apogee (addendum to the Medtronic, Inc. Product Surveillance Registry / Destination Therapy (DT) Post Approval Study (PAS)) Platform Addendum - Mayo Clinic

   The primary purpose of this study is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products ...

10. A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements. - Mayo Clinic

    The secondary goal is to asses clinical endopoints associated with standard of care therapies for TCR MM, in a real-world setting during 12 months of ...